268 related articles for article (PubMed ID: 31619018)
1. The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.
Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.
Futakuchi M; Nitanda T; Ando S; Matsumoto H; Yoshimoto E; Fukamachi K; Suzui M
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547583
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.
Sato S; Futakuchi M; Ogawa K; Asamoto M; Nakao K; Asai K; Shirai T
Cancer Sci; 2008 Feb; 99(2):316-23. PubMed ID: 18271931
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.
Nyman JS; Merkel AR; Uppuganti S; Nayak B; Rowland B; Makowski AJ; Oyajobi BO; Sterling JA
Bone; 2016 Oct; 91():81-91. PubMed ID: 27423464
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
11. PEG10 counteracts signaling pathways of TGF-β and BMP to regulate growth, motility and invasion of SW1353 chondrosarcoma cells.
Yahiro Y; Maeda S; Shinohara N; Jokoji G; Sakuma D; Setoguchi T; Ishidou Y; Nagano S; Komiya S; Taniguchi N
J Bone Miner Metab; 2019 May; 37(3):441-454. PubMed ID: 30094509
[TBL] [Abstract][Full Text] [Related]
12. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
14. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction.
Wilson TJ; Nannuru KC; Singh RK
Mol Cancer Res; 2009 Aug; 7(8):1224-33. PubMed ID: 19671689
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
18. TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth.
Marvin DL; Dijkstra J; Zulfiqar RM; Vermeulen M; Ten Dijke P; Ritsma L
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240029
[TBL] [Abstract][Full Text] [Related]
19. Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.
Buenrostro D; Kwakwa KA; Putnam NE; Merkel AR; Johnson JR; Cassat JE; Sterling JA
Bone; 2018 Aug; 113():77-88. PubMed ID: 29753718
[TBL] [Abstract][Full Text] [Related]
20. Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition.
Zuo ZQ; Chen KG; Yu XY; Zhao G; Shen S; Cao ZT; Luo YL; Wang YC; Wang J
Biomaterials; 2016 Mar; 82():48-59. PubMed ID: 26751819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
